Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine A2b receptor pseudogene 1 (ADORA2BP1) is a non-functional genomic sequence that closely resembles the A2b adenosine receptor gene but cannot encode a functional receptor protein. Its sequence shares high identity (about 79%) with the coding sequence of the real adenosine A2b receptor gene (ADORA2B), but it is unable to produce an active receptor due to accumulated mutations or deletions[2][6][10][1][8]. The functional adenosine A2b receptor (ADORA2B), not the pseudogene, mediates physiological responses through G protein-coupled signaling and is a validated therapeutic target in fields such as inflammation, vascular physiology, and cancer[5][7][9]; ADORA2BP1 plays no direct role in these processes. In summary: ADORA2BP1 (Adenosine A2b receptor pseudogene 1) is a pseudogene, not a receptor; it is neither a therapeutic target nor relevant for drug development or disease roles, and is often incorrectly cited as a target due to confusion with the functional adenosine A2b receptor (ADORA2B)[1][2][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine A2b receptor pseudogene 1 (ADORA2BP1).